Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin

Health-related quality of life association with weight change in type 2 diabetes mellitus: perception vs. reality

(2013) S. Grandy et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study

(2012)   DIABETES CARE

Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement

(2012) L. E. Egede et al.   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin

(2012) Ö. Ljunggren et al.   DIABETES OBESITY & METABOLISM

Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus

(2012) M. Davies et al.   DIABETES OBESITY & METABOLISM

Greater Adherence To Diabetes Drugs Is Linked To Less Hospital Use And Could Save Nearly $5 Billion Annually

(2012) Ashish K. Jha et al.   HEALTH AFFAIRS

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

(2012) Jan Bolinder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The 'cost' of medication nonadherence: Consequences we cannot afford to accept

(2012) Marie A. Chisholm-Burns et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

(2011) M. A. Nauck et al.   DIABETES CARE

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial

(2011) K. Strojek et al.   DIABETES OBESITY & METABOLISM

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

(2010) Clifford J Bailey et al.   LANCET